{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:34:45Z","timestamp":1791304485370,"version":"4.3.1"},"reference-count":28,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background:<\/jats:bold>Gestational hypertension (GH) and pre eclampsia (PE) are the most common gestational complications. Several placental biochemical markers are used to predict GH\/PE, but with conflicting results.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>The study aim was to estimate the biochemical markers\u2019 ability to predict hypertensive disorders in pregnancy. On the first ultrasonographic examination, 104 healthy pregnant women were recruited. At the regular pregnancy check-ups, BMI, blood pressure, occurrence of gestational hypertension (early or late onset), preeclampsia, eclampsia and other complications were recorded. Serum concentrations (in multiples of median \u2013 MoM) of human chorionic gonadotropin (HCG) and pregnancyassociated plasma protein A (PAPPA) were measured from the 11th to 14th gestational week, while HCG, alpha feto protein (AFP), estriol and inhibin were determined between the 16th and 19th gestational week.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Hypertensive disorders throughout pregnancy were diagnosed in 20.2% women. Early-onset GH was registered in 7 and PE in 6 patients, while 14 had late-onset GH and 10 additional women PE. There were no significant differences (p\u22650.05) in biochemical markers concentrations between women with and without GH\/PE. PAPPA levels in the first and HCG in the second trimester correlated with early and late GH\/PE. Moreover, higher AFP concentrations were registered in women with preeclampsia signs\/symptoms. According to ROC analysis, AFP&gt;1.05 MoM properly identified 80% of GH\/PE cases. Obtained models imply that HCG, PAPPA and AFP should be used for GH\/PE prediction.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>Biochemical markers HCG, PAPPA and AFP could be useful in predicting gestational hypertension and preeclampsia. However, different markers should be used for early and late onset GH\/PE.<\/jats:p>","DOI":"10.2478\/jomb-2018-0001","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T22:16:42Z","timestamp":1526077002000},"page":"71-82","source":"Crossref","is-referenced-by-count":22,"title":["Biochemical Markers for Prediction of Hypertensive Disorders of Pregnancy"],"prefix":"10.5937","volume":"38","author":[{"given":"Du\u0161ica Kocijan\u010di\u0107","family":"Belovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sne\u017eana","family":"Ple\u0161inac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Dotli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Savi\u0107","family":"Radojevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Ak\u0161am","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana Marjanovi\u0107","family":"Cvjeti\u0107anin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Kocijan\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.placenta.2011.11.021","article-title":"biochemical markers to predict preeclampsia","volume":"12","author":"Anderson","year":"2012","journal-title":"Review Placenta"},{"key":"ref191","first-page":"471","article-title":"Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome","volume":"20","author":"Huang","year":"2010"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1159\/000458409","article-title":"Predictive Value of Second - Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes","volume":"17","author":"Yefet","year":"2017","journal-title":"Fetal Diagn Ther"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/HYPERTENSIONAHA.111.201624","article-title":"SO Aberrant synthesis metabolism and plasma accumulation of circulating estro gens and estrogen metabolites in preeclampsia : implications for vascular dysfunction","volume":"21","author":"Jobe","year":"2013","journal-title":"Hypertension"},{"key":"ref51","first-page":"295","article-title":"AS Decreased thelial Progenitor Cells and increased Natural Killer cells in peripheral blood as possible early markers of preeclampsia : a case - control analysis","author":"Lagana","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"ref11","first-page":"215","article-title":"Co - stantine Placental origins of adverse pregnancy out - comes : potential molecular targets : an Executive Work - shop Summary of the Eunice National Institute of Child","author":"Ilekis","year":"2016","journal-title":"Health Human Development Am J Obstet Gynecol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000322742","article-title":"PH Huh Early detection of preeclampsia using inhibin a and other second - trimester serum markers","volume":"16","author":"Ree","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"ref291","first-page":"208","article-title":"Performance of a first - trimester screening of preeclampsia in a routine care low - risk setting","volume":"30","author":"Scazzocchio","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"ref311","first-page":"225","article-title":"Schielen PC Evaluation of serum biomarkers and uterine artery Doppler ultrasound for first - trimester prediction of preeclampsia : a systematic","author":"Wortelboer","year":"2011","journal-title":"review Obstet Gynecol Surv"},{"key":"ref231","first-page":"175","article-title":"Performance of first trimester biochemical markers and mean arterial pressure in prediction of early - onset pre - eclampsia Experiment","volume":"24","author":"Nevalainen","year":"2017","journal-title":"Metabolism"},{"key":"ref281","first-page":"279","article-title":"Firsttrimester prediction of pre - eclampsia : external validity of algorithms in a prospectively enrolled cohort Ultra - sound","volume":"29","author":"Oliveira","year":"2014","journal-title":"Obstet Gynecol"},{"key":"ref21","first-page":"211","article-title":"Prediction of preeclampsia utilizing the first trimester screening exam ination","author":"Baschat","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pd.4397","article-title":"First - trimester maternal factors and biomarker screening for preeclampsia","volume":"11","author":"Poon","year":"2014","journal-title":"Prenatal Diagnosis"},{"key":"ref141","first-page":"207","article-title":"Abnormal second - trimester serum analytes are more predictive of preterm preeclampsia","volume":"15","author":"Olsen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref301","first-page":"538","article-title":"Prediction of early and late pre - eclampsia from maternal characteristics uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy Ultrasound","volume":"31","author":"Parra Cordero","year":"2013","journal-title":"Obstet Gynecol"},{"key":"ref271","first-page":"138","article-title":"Assessment of serum \u03b2 - hCG and lipid profile in early second trimester as predictors of hypertensive disorders of pregnancy","volume":"28","author":"Revankar","year":"2017","journal-title":"Int J Gynecol Obstet"},{"key":"ref81","first-page":"245","article-title":"Pre eclampsia overview on the role of biomarkers in","author":"Paridaens","year":"2016","journal-title":"Ann Biol Clin Paris"},{"key":"ref211","first-page":"181","article-title":"AT EM Predictive value of combined serum biomarkers for adverse pregnancy outcomes Euro","volume":"22","author":"Cohen","year":"2014","journal-title":"Obstet Gynecol Reprod Biol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1515\/jomb-2015-0020","article-title":"AS Lack of association between angiotensin converting enzyme i d polymorphism and unexplained recurrent miscarriage in Saudi Arabia","volume":"25","author":"Mukaynizi","year":"2016","journal-title":"J Med Biochem"},{"key":"ref261","first-page":"2015","article-title":"Early - onset severe preeclampsia by first trimester pregnancy - associated plasma protein and total human chorionic gonadotropin","volume":"27","author":"Jelliffe","journal-title":"Am J Perinatol"},{"key":"ref171","first-page":"194","article-title":"Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin","volume":"18","author":"Towner","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"ref181","first-page":"136","article-title":"Low maternal pregnancy - associated plasma protein A during the first trimester of pregnancy and pregnancy outcomes","volume":"19","author":"Kaijomaa","year":"2017","journal-title":"Int J Gynecol Obstet"},{"key":"ref221","first-page":"2015","article-title":"The value of maternal first and second trimester serum data of \u03b2 - hCG uE in the prediction of preeclampsia","volume":"23","author":"Gu"},{"key":"ref61","first-page":"53","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","author":"Park","year":"2013"},{"key":"ref131","first-page":"162","article-title":"First trimester serum markers to predict preeclampsia","volume":"14","author":"Huppertz","year":"2012","journal-title":"Wien Med Wochenschr"},{"key":"ref01","first-page":"1","article-title":"derived biomarkers of pregnancy disorders","author":"Cuffe","year":"2017","journal-title":"Review Placenta"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.placenta.2012.03.003","article-title":"First trimester maternal serum free hCG uterine artery Doppler and maternal history for the prediction of preeclampsia","volume":"13","author":"Di Lorenzo","year":"2012","journal-title":"Placenta"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.10.024","article-title":"First - trimester screening for early and late preeclampsia using maternal characteristics and estimated placental volume","author":"Sonek","year":"2017","journal-title":"biomarkers Am J Obstet Gynecol"}],"container-title":["Journal of Medical Biochemistry"],"original-title":[],"link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/jomb\/38\/1\/article-p71.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2019\/1452-82581901071K.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T22:07:43Z","timestamp":1604268463000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/article.aspx?artid=1452-82581901071K"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":28,"aliases":["10.1515\/jomb-2018-0001"],"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2478\/jomb-2018-0001","relation":{},"ISSN":["1452-8266"],"issn-type":[{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}